{{Rsnum
|rsid=2387084
|Chromosome=16
|position=74054192
|Orientation=plus
|GMAF=0.3462
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 10.7 | 45.5 | 43.8
| HCB | 22.6 | 46.7 | 30.7
| JPT | 31.0 | 55.8 | 13.3
| YRI | 4.1 | 45.2 | 50.7
| ASW | 8.9 | 44.6 | 46.4
| CHB | 22.6 | 46.7 | 30.7
| CHD | 18.3 | 49.5 | 32.1
| GIH | 9.9 | 39.6 | 50.5
| LWK | 10.9 | 36.4 | 52.7
| MEX | 8.6 | 34.5 | 56.9
| MKK | 12.8 | 42.9 | 44.2
| TSI | 14.7 | 39.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=23920401
|Title=Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}